Literature DB >> 18949111

Current state for the development of metallopharmaceutics and anti-diabetic metal complexes.

Hiromu Sakurai1, Yutaka Yoshikawa, Hiroyuki Yasui.   

Abstract

This tutorial review introduces the current state of metallopharmaceutics development by focusing on the topics of anti-diabetic vanadium and zinc complexes. Over thousands of years, people have produced many types of inorganic compounds, and the modern concept of chemotherapy was achieved by Ehrlich, who used an arsenic-containing compound to treat syphilis. Since then, many metallopharmaceutics have been developed worldwide. This review will be helpful to researchers who are interested in the current states of not only metallopharmaceutics but also anti-diabetic metal complexes.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18949111     DOI： 10.1039/b710347f

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN： 0306-0012            Impact factor:   54.564


  17 in total

1.  Vanadyl bisacetylacetonate protects β cells from palmitate-induced cell death through the unfolded protein response pathway.

Authors:  Zhonglan Gao; Chengyue Zhang; Siwang Yu; Xiaoda Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2011-04-22       Impact factor: 3.358

2.  Application of DFT methods to the study of the coordination environment of the VO2+ ion in V proteins.

Authors:  Daniele Sanna; Vincent L Pecoraro; Giovanni Micera; Eugenio Garribba
Journal:  J Biol Inorg Chem       Date:  2012-04-15       Impact factor: 3.358

3.  Identification of a potent activator of Akt phosphorylation from a novel series of phenolic, picolinic, pyridino, and hydroxamic zinc(II) complexes.

Authors:  Savvas N Georgiades; Lok Hang Mak; Inmaculada Angurell; Evelyn Rosivatz; M Firouz Mohd Mustapa; Christoulla Polychroni; Rudiger Woscholski; Ramon Vilar
Journal:  J Biol Inorg Chem       Date:  2010-10-23       Impact factor: 3.358

4.  Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution.

Authors:  Debbie C Crans; Boyan Zhang; Ernestas Gaidamauskas; Anastasios D Keramidas; Gail R Willsky; Chris R Roberts
Journal:  Inorg Chem       Date:  2010-05-03       Impact factor: 5.165

5.  Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species.

Authors:  Qin Wang; Tong-Tong Liu; Ying Fu; Kui Wang; Xiao-Gai Yang
Journal:  J Biol Inorg Chem       Date:  2010-05-05       Impact factor: 3.358

6.  Antidiabetic vanadium compound and membrane interfaces: interface-facilitated metal complex hydrolysis.

Authors:  Debbie C Crans; Samantha Schoeberl; Ernestas Gaidamauskas; Bharat Baruah; Deborah A Roess
Journal:  J Biol Inorg Chem       Date:  2011-06-11       Impact factor: 3.358

7.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

8.  Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.

Authors:  Alvin A Holder; Patrick Taylor; Anthony R Magnusen; Erick T Moffett; Kyle Meyer; Yiling Hong; Stuart E Ramsdale; Michelle Gordon; Javelyn Stubbs; Luke A Seymour; Dhiraj Acharya; Ralph T Weber; Paul F Smith; G Charles Dismukes; Ping Ji; Laura Menocal; Fengwei Bai; Jennie L Williams; Donald M Cropek; William L Jarrett
Journal:  Dalton Trans       Date:  2013-09-07       Impact factor: 4.390

9.  Hypoglycemic Properties of Oxovanadium (IV) Coordination Compounds with Carboxymethyl-Carrageenan and Carboxymethyl-Chitosan in Alloxan-Induced Diabetic Mice.

Authors:  Hongyu Zhang; Yuetao Yi; Dawei Feng; Yipeng Wang; Song Qin
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-26       Impact factor: 2.629

Review 10.  Zinc homeostasis and signaling in health and diseases: Zinc signaling.

Authors:  Toshiyuki Fukada; Satoru Yamasaki; Keigo Nishida; Masaaki Murakami; Toshio Hirano
Journal:  J Biol Inorg Chem       Date:  2011-06-10       Impact factor: 3.358
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.